CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma

SIMPLE SUMMARY: Available data on anti-BCMA CART-cell therapy has demonstrated efficacy and manageable toxicity in heavily pretreated R/R MM patients. Despite this, the main issues remain to be addressed. First of all, a significant proportion of patients eventually relapse. The potential strategy t...

Descripción completa

Detalles Bibliográficos
Autores principales: Martino, Massimo, Canale, Filippo Antonio, Alati, Caterina, Vincelli, Iolanda Donatella, Moscato, Tiziana, Porto, Gaetana, Loteta, Barbara, Naso, Virginia, Mazza, Massimiliano, Nicolini, Fabio, Ghelli Luserna di Rorà, Andrea, Simonetti, Giorgia, Ronconi, Sonia, Ceccolini, Michela, Musuraca, Gerardo, Martinelli, Giovanni, Cerchione, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197914/
https://www.ncbi.nlm.nih.gov/pubmed/34072068
http://dx.doi.org/10.3390/cancers13112639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197914/
https://www.ncbi.nlm.nih.gov/pubmed/34072068
http://dx.doi.org/10.3390/cancers13112639

Ejemplares similares